00787nas a2200301   4500000000100000000000100001008004100002653002000043653001800063653001700081653002100098653001100119100001700130700001300147700001400160700001500174700001500189700001300204700001800217700001500235700001500250700001400265700001400279700001600293245014700309250001500456020001400471       2024                            d10aCausal analysis10aEffectiveness10aOlder Adults10aSGLT2 inhibitors10aSafety1 aL. Güdemann1 aK. Young1 aN. Thomas1 aR. Hopkins1 aR. Challen1 aA. Jones1 aA. Hattersley1 aE. Pearson1 aB. Shields1 aJ. Bowden1 aJ. Dennis1 aA. McGovern00aSafety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approach  a2024/06/05  a0012-186x